IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on ...

About a year after beginning its full market launch, Masimo’s W1 smartwatch can now be used as a medical device in the U.S. The wearable device has earned FDA clearance for its medical applications, ...

Masimo (Nasdaq: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient ...

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient ...

Masimo MASI announced that Fresno, a California-based Community Health System (CHS), is using Masimo SET pulse oximetry as a standard device across its network of hospitals. CHS provides all levels of ...

Masimo CEO Joe Kiani took advantage of an interview to slam Apple's implementation of pulse oximetry in the Apple Watch, and confirm that there have not been recent settlement talks. Masimo CEO Joe ...